Informações:
Falhas:
ID
34413
Descrição
Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01753375
Link
https://clinicaltrials.gov/show/NCT01753375
Palavras-chave
Versões (1)
- 17/01/2019 17/01/2019 -
Titular dos direitos
GSK group of companies
Transferido a
17 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Multiple Sclerosis NCT01753375
Eligibility Multiple Sclerosis NCT01753375
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT01753375
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
age between 18-55 years
boolean
ID.2
Item
confirmed multiple sclerosis diagnosis according to mcdonald criteria
boolean
ID.3
Item
stable neurological functioning for at least one month prior to study entry
boolean
ID.4
Item
expanded disability scale score (edss) less than <_4.0
boolean
ID.5
Item
must have had one clinical attack in past two years and at least one new silent t2 or gadolinium-enhancing lesion on mri within the past one year.
boolean
ID.6
Item
willing to participate for the entire 52-week period
boolean
ID.7
Item
pregnant or nursing.
boolean
ID.8
Item
connective tissue disease (sle, sjogren's disease)
boolean
ID.9
Item
endocrine disease (hyperthyroidism, hyperparathyroidism)
boolean
ID.10
Item
any medical condition predisposing to hypercalcaemia, nephrolithiasis or renal insufficiency
boolean